New Patent to Discover Sophisticated Cell Penetrating Drugs
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- Combination therapy escalates potency of Phylogica peptides
- US Patent Synthetic Phylomer Libraries
- US Patent granted
- Roche Collaboration Extended
- Response to ASX Query - Price Query
Later from PYC Therapeutics
- Core patent granted in Australia
- European Patent Granted
- R&D tax offset refund
- Pfizer First Stage of Collaboration Complete
- Share Placement raises $2.15 Million
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics